BELCHER PHARMACEUTICALS, LLC v. HOSPIRA, INC.

2020-1799.

11 F.4th 1345 (2021)

BELCHER PHARMACEUTICALS, LLC, Plaintiff-Appellant v. HOSPIRA, INC., Defendant-Appellee.

United States Court of Appeals, Federal Circuit.

Decided: September 1, 2021.


Attorney(s) appearing for the Case

Peter Mccreery Lancaster , Dorsey & Whitney LLP, Minneapolis, MN, argued for plaintiff-appellant. Also represented by Kenneth Levitt .

Matthew S. Freimuth , Willkie Farr & Gallagher LLP, New York, NY, argued for defendant-appellee. Also represented by Devon Wesley Edwards , Thomas J. Meloro .

Before Reyna, Taranto, and Stoll, Circuit Judges.


This is an appeal from a decision of the U.S. District Court for the District of Delaware that U.S. Patent No. 9,283,197, which Appellant Belcher Pharmaceuticals, LLC asserted against Appellee Hospira, Inc. in a patent infringement suit under the Hatch-Waxman Act, is unenforceable for inequitable conduct. The district court...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases